ORCID Profile
0000-0003-4978-9703
Current Organisation
Universidade do Estado de Santa Catarina
Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the Feedback Form.
Publisher: American Association for Cancer Research (AACR)
Date: 04-04-2023
DOI: 10.1158/1055-9965.22552114.V1
Abstract: Supplementary Table 1 presents the search terminology used in the systematic review
Publisher: American Association for Cancer Research (AACR)
Date: 04-04-2023
DOI: 10.1158/1055-9965.22552135
Abstract: Supplementary Figure 1A presents forest plots for physical activity and CRP, by menopausal status
Publisher: American Association for Cancer Research (AACR)
Date: 05-2023
DOI: 10.1158/1055-9965.22725233.V1
Abstract: Supplementary Table 1 presents the search terminology used in the systematic review
Publisher: American Association for Cancer Research (AACR)
Date: 04-04-2023
DOI: 10.1158/1055-9965.22552099
Abstract: Supplementary Table 2C presents the study characteristics for non-randomised interventions
Publisher: American Association for Cancer Research (AACR)
Date: 04-04-2023
DOI: 10.1158/1055-9965.22552132
Abstract: Supplementary Figure 1B presents forest plots for physical activity and CRP, by exercise type
Publisher: American Association for Cancer Research (AACR)
Date: 29-03-2023
DOI: 10.1158/1055-9965.22354240.V1
Abstract: Supplementary Table 6C presents findings of in idual non-randomised interventions
Publisher: American Association for Cancer Research (AACR)
Date: 04-04-2023
DOI: 10.1158/1055-9965.22552096
Abstract: Supplementary Table 2D presents the study characteristics of the prospective cohort study
Publisher: American Association for Cancer Research (AACR)
Date: 29-03-2023
DOI: 10.1158/1055-9965.22354267
Abstract: Supplementary Table 2C presents the study characteristics for non-randomised interventions
Publisher: American Association for Cancer Research (AACR)
Date: 04-04-2023
DOI: 10.1158/1055-9965.22552093
Abstract: Supplementary Table 3A presents the risk of bias for randomised controlled and randomised cross-over trials, using the Cochrane Collaboration Tool
Publisher: American Association for Cancer Research (AACR)
Date: 29-03-2023
DOI: 10.1158/1055-9965.22354264
Abstract: Supplementary Table 2D presents the study characteristics of the prospective cohort study
Publisher: American Association for Cancer Research (AACR)
Date: 05-2023
DOI: 10.1158/1055-9965.22725227.V1
Abstract: Supplementary Table 2B presents the study characteristics of randomised cross-over trials
Publisher: American Association for Cancer Research (AACR)
Date: 04-04-2023
DOI: 10.1158/1055-9965.22552090
Abstract: Supplementary Table 3B presents the risk of bias for non-randomised interventions, using the ROBINS-I
Publisher: American Association for Cancer Research (AACR)
Date: 29-03-2023
DOI: 10.1158/1055-9965.22354261
Abstract: Supplementary Table 3A presents the risk of bias for randomised controlled and randomised cross-over trials, using the Cochrane Collaboration Tool
Publisher: American Association for Cancer Research (AACR)
Date: 29-03-2023
DOI: 10.1158/1055-9965.22354258
Abstract: Supplementary Table 3B presents the risk of bias for non-randomised interventions, using the ROBINS-I
Publisher: American Association for Cancer Research (AACR)
Date: 05-2023
DOI: 10.1158/1055-9965.22725212
Abstract: Supplementary Table 3C present the risk of bias for the prospective cohort study, using the ROBINS-E
Publisher: American Association for Cancer Research (AACR)
Date: 04-04-2023
DOI: 10.1158/1055-9965.22552072.V1
Abstract: Supplementary Table 6C presents findings of in idual non-randomised interventions
Publisher: American Association for Cancer Research (AACR)
Date: 05-2023
DOI: 10.1158/1055-9965.22725215
Abstract: Supplementary Table 3B presents the risk of bias for non-randomised interventions, using the ROBINS-I
Publisher: American Association for Cancer Research (AACR)
Date: 04-04-2023
DOI: 10.1158/1055-9965.22552120.V1
Abstract: Supplementary Figure 3B presents forest plots for physical activity and IL-6, by exercise type
Publisher: American Association for Cancer Research (AACR)
Date: 05-08-0004
DOI: 10.1158/1055-9965.22552129
Abstract: Supplementary Figure 2A present forest plots for physical activity and TNF-alpha, by menopausal status
Publisher: American Association for Cancer Research (AACR)
Date: 05-2023
DOI: 10.1158/1055-9965.22725218.V1
Abstract: Supplementary Table 3A presents the risk of bias for randomised controlled and randomised cross-over trials, using the Cochrane Collaboration Tool
Publisher: American Association for Cancer Research (AACR)
Date: 05-2023
DOI: 10.1158/1055-9965.C.6491050
Abstract: Abstract The protective effect of physical activity on breast cancer incidence may partially be mediated by inflammation. Systematic searches of Medline, EMBASE, and SPORTDiscus were performed to identify intervention studies, Mendelian randomization studies, and prospective cohort studies that examined the effects of physical activity on circulating inflammatory biomarkers in adult women. Meta-analyses were performed to generate effect estimates. Risk of bias was assessed, and the Grading of Recommendations Assessment, Development, and Evaluation system was used to determine the overall quality of the evidence. Thirty-five intervention studies and one observational study met the criteria for inclusion. Meta-analyses of randomized controlled trials (RCT) indicated that, compared with control groups, exercise interventions reduced levels of C-reactive protein (CRP) [standardized mean difference (SMD) = −0.27, 95% confidence interval (CI) = −0.62 to 0.08), tumor necrosis factor alpha (TNFα, SMD = −0.63, 95% CI = −1.04 to −0.22), interleukin-6 (IL6, SMD = −0.55, 95% CI = −0.97 to −0.13) and leptin (SMD = −0.50, 95% CI = −1.10 to 0.09). Owing to heterogeneity in effect estimates and imprecision, evidence strength was graded as low (CRP, leptin) or moderate (TNFα and IL6). High-quality evidence indicated that exercise did not change adiponectin levels (SMD = 0.01, 95% CI = −0.14 to 0.17). These findings provide support for the biological plausibility of the first part of the physical activity—inflammation—breast cancer pathway. /
Publisher: American Association for Cancer Research (AACR)
Date: 05-2023
DOI: 10.1158/1055-9965.22725218
Abstract: Supplementary Table 3A presents the risk of bias for randomised controlled and randomised cross-over trials, using the Cochrane Collaboration Tool
Publisher: American Association for Cancer Research (AACR)
Date: 04-04-2023
DOI: 10.1158/1055-9965.22552126
Abstract: Supplementary Figure 2B presents forest plots for physical activity and TNF-alpha, by exercise type
Publisher: American Association for Cancer Research (AACR)
Date: 05-2023
DOI: 10.1158/1055-9965.22725209.V1
Abstract: Supplementary Table 4 presents the outcomes of the meta-regression analysis conducted for CRP
Publisher: American Association for Cancer Research (AACR)
Date: 29-03-2023
DOI: 10.1158/1055-9965.C.6491050.V1
Abstract: Abstract The protective effect of physical activity on breast cancer incidence may partially be mediated by inflammation. Systematic searches of Medline, EMBASE, and SPORTDiscus were performed to identify intervention studies, Mendelian randomization studies, and prospective cohort studies that examined the effects of physical activity on circulating inflammatory biomarkers in adult women. Meta-analyses were performed to generate effect estimates. Risk of bias was assessed, and the Grading of Recommendations Assessment, Development, and Evaluation system was used to determine the overall quality of the evidence. Thirty-five intervention studies and one observational study met the criteria for inclusion. Meta-analyses of randomized controlled trials (RCT) indicated that, compared with control groups, exercise interventions reduced levels of C-reactive protein (CRP) [standardized mean difference (SMD) = −0.27, 95% confidence interval (CI) = −0.62 to 0.08), tumor necrosis factor alpha (TNFα, SMD = −0.63, 95% CI = −1.04 to −0.22), interleukin-6 (IL6, SMD = −0.55, 95% CI = −0.97 to −0.13) and leptin (SMD = −0.50, 95% CI = −1.10 to 0.09). Owing to heterogeneity in effect estimates and imprecision, evidence strength was graded as low (CRP, leptin) or moderate (TNFα and IL6). High-quality evidence indicated that exercise did not change adiponectin levels (SMD = 0.01, 95% CI = −0.14 to 0.17). These findings provide support for the biological plausibility of the first part of the physical activity—inflammation—breast cancer pathway. /
Publisher: American Association for Cancer Research (AACR)
Date: 04-04-2023
DOI: 10.1158/1055-9965.22552081.V1
Abstract: Supplementary Table 5 presents the outcomes of the meta-regression analysis conducted for IL-6
Publisher: American Association for Cancer Research (AACR)
Date: 05-2023
DOI: 10.1158/1055-9965.C.6491050.V3
Abstract: Abstract The protective effect of physical activity on breast cancer incidence may partially be mediated by inflammation. Systematic searches of Medline, EMBASE, and SPORTDiscus were performed to identify intervention studies, Mendelian randomization studies, and prospective cohort studies that examined the effects of physical activity on circulating inflammatory biomarkers in adult women. Meta-analyses were performed to generate effect estimates. Risk of bias was assessed, and the Grading of Recommendations Assessment, Development, and Evaluation system was used to determine the overall quality of the evidence. Thirty-five intervention studies and one observational study met the criteria for inclusion. Meta-analyses of randomized controlled trials (RCT) indicated that, compared with control groups, exercise interventions reduced levels of C-reactive protein (CRP) [standardized mean difference (SMD) = −0.27, 95% confidence interval (CI) = −0.62 to 0.08), tumor necrosis factor alpha (TNFα, SMD = −0.63, 95% CI = −1.04 to −0.22), interleukin-6 (IL6, SMD = −0.55, 95% CI = −0.97 to −0.13) and leptin (SMD = −0.50, 95% CI = −1.10 to 0.09). Owing to heterogeneity in effect estimates and imprecision, evidence strength was graded as low (CRP, leptin) or moderate (TNFα and IL6). High-quality evidence indicated that exercise did not change adiponectin levels (SMD = 0.01, 95% CI = −0.14 to 0.17). These findings provide support for the biological plausibility of the first part of the physical activity—inflammation—breast cancer pathway. /
Publisher: American Association for Cancer Research (AACR)
Date: 05-2023
DOI: 10.1158/1055-9965.22725236.V1
Abstract: GRADE appraisal for physical activity–inflammatory biomarkers pathways.
Publisher: American Association for Cancer Research (AACR)
Date: 04-04-2023
DOI: 10.1158/1055-9965.C.6491050.V2
Abstract: Abstract The protective effect of physical activity on breast cancer incidence may partially be mediated by inflammation. Systematic searches of Medline, EMBASE, and SPORTDiscus were performed to identify intervention studies, Mendelian randomization studies, and prospective cohort studies that examined the effects of physical activity on circulating inflammatory biomarkers in adult women. Meta-analyses were performed to generate effect estimates. Risk of bias was assessed, and the Grading of Recommendations Assessment, Development, and Evaluation system was used to determine the overall quality of the evidence. Thirty-five intervention studies and one observational study met the criteria for inclusion. Meta-analyses of randomized controlled trials (RCT) indicated that, compared with control groups, exercise interventions reduced levels of C-reactive protein (CRP) [standardized mean difference (SMD) = −0.27, 95% confidence interval (CI) = −0.62 to 0.08), tumor necrosis factor alpha (TNFα, SMD = −0.63, 95% CI = −1.04 to −0.22), interleukin-6 (IL6, SMD = −0.55, 95% CI = −0.97 to −0.13) and leptin (SMD = −0.50, 95% CI = −1.10 to 0.09). Owing to heterogeneity in effect estimates and imprecision, evidence strength was graded as low (CRP, leptin) or moderate (TNFα and IL6). High-quality evidence indicated that exercise did not change adiponectin levels (SMD = 0.01, 95% CI = −0.14 to 0.17). These findings provide support for the biological plausibility of the first part of the physical activity—inflammation—breast cancer pathway. /
Publisher: American Association for Cancer Research (AACR)
Date: 04-04-2023
DOI: 10.1158/1055-9965.22552075.V1
Abstract: Supplementary Table 6B presents findings of in idual randomised cross-over studies
Publisher: American Association for Cancer Research (AACR)
Date: 29-03-2023
DOI: 10.1158/1055-9965.22354243.V1
Abstract: Supplementary Table 6B presents findings of in idual randomised cross-over studies
Publisher: American Association for Cancer Research (AACR)
Date: 29-03-2023
DOI: 10.1158/1055-9965.22354255
Abstract: Supplementary Table 3C present the risk of bias for the prospective cohort study, using the ROBINS-E
Publisher: American Association for Cancer Research (AACR)
Date: 04-04-2023
DOI: 10.1158/1055-9965.22552132.V1
Abstract: Supplementary Figure 1B presents forest plots for physical activity and CRP, by exercise type
Publisher: American Association for Cancer Research (AACR)
Date: 05-2023
DOI: 10.1158/1055-9965.22725242.V1
Abstract: Supplementary Figure 3B presents forest plots for physical activity and IL-6, by exercise type
Publisher: American Association for Cancer Research (AACR)
Date: 04-04-2023
DOI: 10.1158/1055-9965.22552111.V1
Abstract: Supplementary Table 2A presents the study characteristics for parallel group RCTs
Publisher: American Association for Cancer Research (AACR)
Date: 29-03-2023
DOI: 10.1158/1055-9965.22354252
Abstract: Supplementary Table 4 presents the outcomes of the meta-regression analysis conducted for CRP
Publisher: American Association for Cancer Research (AACR)
Date: 29-03-2023
DOI: 10.1158/1055-9965.22354249
Abstract: Supplementary Table 5 presents the outcomes of the meta-regression analysis conducted for IL-6
Publisher: American Association for Cancer Research (AACR)
Date: 05-2023
DOI: 10.1158/1055-9965.22725200
Abstract: Supplementary Table 6B presents findings of in idual randomised cross-over studies
Publisher: American Association for Cancer Research (AACR)
Date: 29-03-2023
DOI: 10.1158/1055-9965.22354246
Abstract: Supplementary Table 6A presents findings of in idual parallel group RCTs
Publisher: American Association for Cancer Research (AACR)
Date: 04-04-2023
DOI: 10.1158/1055-9965.22552108.V1
Abstract: Supplementary Table 2B presents the study characteristics of randomised cross-over trials
Publisher: American Association for Cancer Research (AACR)
Date: 05-2023
DOI: 10.1158/1055-9965.22725203
Abstract: Supplementary Table 6A presents findings of in idual parallel group RCTs
Publisher: American Association for Cancer Research (AACR)
Date: 05-2023
DOI: 10.1158/1055-9965.22725215.V1
Abstract: Supplementary Table 3B presents the risk of bias for non-randomised interventions, using the ROBINS-I
Publisher: American Association for Cancer Research (AACR)
Date: 05-2023
DOI: 10.1158/1055-9965.22725206
Abstract: Supplementary Table 5 presents the outcomes of the meta-regression analysis conducted for IL-6
Publisher: American Association for Cancer Research (AACR)
Date: 05-2023
DOI: 10.1158/1055-9965.22725209
Abstract: Supplementary Table 4 presents the outcomes of the meta-regression analysis conducted for CRP
Publisher: American Association for Cancer Research (AACR)
Date: 29-03-2023
DOI: 10.1158/1055-9965.22354294.V1
Abstract: Supplementary Figure 1B presents forest plots for physical activity and CRP, by exercise type
Publisher: American Association for Cancer Research (AACR)
Date: 29-03-2023
DOI: 10.1158/1055-9965.22354246.V1
Abstract: Supplementary Table 6A presents findings of in idual parallel group RCTs
Publisher: American Association for Cancer Research (AACR)
Date: 04-04-2023
DOI: 10.1158/1055-9965.22552078.V1
Abstract: Supplementary Table 6A presents findings of in idual parallel group RCTs
Publisher: American Association for Cancer Research (AACR)
Date: 04-04-2023
DOI: 10.1158/1055-9965.22552084.V1
Abstract: Supplementary Table 4 presents the outcomes of the meta-regression analysis conducted for CRP
Publisher: American Association for Cancer Research (AACR)
Date: 03-03-2023
DOI: 10.1158/1055-9965.EPI-22-0928
Abstract: The protective effect of physical activity on breast cancer incidence may partially be mediated by inflammation. Systematic searches of Medline, EMBASE, and SPORTDiscus were performed to identify intervention studies, Mendelian randomization studies, and prospective cohort studies that examined the effects of physical activity on circulating inflammatory biomarkers in adult women. Meta-analyses were performed to generate effect estimates. Risk of bias was assessed, and the Grading of Recommendations Assessment, Development, and Evaluation system was used to determine the overall quality of the evidence. Thirty-five intervention studies and one observational study met the criteria for inclusion. Meta-analyses of randomized controlled trials (RCT) indicated that, compared with control groups, exercise interventions reduced levels of C-reactive protein (CRP) [standardized mean difference (SMD) = −0.27, 95% confidence interval (CI) = −0.62 to 0.08), tumor necrosis factor alpha (TNFα, SMD = −0.63, 95% CI = −1.04 to −0.22), interleukin-6 (IL6, SMD = −0.55, 95% CI = −0.97 to −0.13) and leptin (SMD = −0.50, 95% CI = −1.10 to 0.09). Owing to heterogeneity in effect estimates and imprecision, evidence strength was graded as low (CRP, leptin) or moderate (TNFα and IL6). High-quality evidence indicated that exercise did not change adiponectin levels (SMD = 0.01, 95% CI = −0.14 to 0.17). These findings provide support for the biological plausibility of the first part of the physical activity—inflammation—breast cancer pathway.
Publisher: American Association for Cancer Research (AACR)
Date: 29-03-2023
DOI: 10.1158/1055-9965.22354288
Abstract: Supplementary Figure 2B presents forest plots for physical activity and TNF-alpha, by exercise type
Publisher: American Association for Cancer Research (AACR)
Date: 29-03-2023
DOI: 10.1158/1055-9965.22354285
Abstract: Supplementary Figure 3A presents forest plots for physical activity and IL-6, by menopausal status
Publisher: American Association for Cancer Research (AACR)
Date: 29-03-2023
DOI: 10.1158/1055-9965.22354288.V1
Abstract: Supplementary Figure 2B presents forest plots for physical activity and TNF-alpha, by exercise type
Publisher: American Association for Cancer Research (AACR)
Date: 29-03-2023
DOI: 10.1158/1055-9965.22354282
Abstract: Supplementary Figure 3B presents forest plots for physical activity and IL-6, by exercise type
Publisher: American Association for Cancer Research (AACR)
Date: 04-04-2023
DOI: 10.1158/1055-9965.22552135.V1
Abstract: Supplementary Figure 1A presents forest plots for physical activity and CRP, by menopausal status
Publisher: American Association for Cancer Research (AACR)
Date: 29-03-2023
DOI: 10.1158/1055-9965.22354261.V1
Abstract: Supplementary Table 3A presents the risk of bias for randomised controlled and randomised cross-over trials, using the Cochrane Collaboration Tool
Publisher: American Association for Cancer Research (AACR)
Date: 05-2023
DOI: 10.1158/1055-9965.22725221.V1
Abstract: Supplementary Table 2D presents the study characteristics of the prospective cohort study
Publisher: American Association for Cancer Research (AACR)
Date: 29-03-2023
DOI: 10.1158/1055-9965.22354252.V1
Abstract: Supplementary Table 4 presents the outcomes of the meta-regression analysis conducted for CRP
Publisher: American Association for Cancer Research (AACR)
Date: 29-03-2023
DOI: 10.1158/1055-9965.22354279
Abstract: Supplementary Figure 4 presents funnel plots for physical activity to inflammatory biomarkers meta-analyses
Publisher: American Association for Cancer Research (AACR)
Date: 04-04-2900
DOI: 10.1158/1055-9965.22552093.V1
Abstract: Supplementary Table 3A presents the risk of bias for randomised controlled and randomised cross-over trials, using the Cochrane Collaboration Tool
Publisher: American Association for Cancer Research (AACR)
Date: 20-10-2022
DOI: 10.1158/1055-9965.EPI-21-0438
Abstract: We undertook a systematic review and appraised the evidence for an effect of circulating sex steroid hormones and sex hormone–binding globulin (SHBG) on breast cancer risk in pre- and postmenopausal women. Systematic searches identified prospective studies relevant to this review. Meta-analyses estimated breast cancer risk for women with the highest compared with the lowest level of sex hormones, and the DRMETA Stata package was used to graphically represent the shape of these associations. The ROBINS-E tool assessed risk of bias, and the GRADE system appraised the strength of evidence. In premenopausal women, there was little evidence that estrogens, progesterone, or SHBG were associated with breast cancer risk, whereas androgens showed a positive association. In postmenopausal women, higher estrogens and androgens were associated with an increase in breast cancer risk, whereas higher SHBG was inversely associated with risk. The strength of the evidence quality ranged from low to high for each hormone. Dose–response relationships between sex steroid hormone concentrations and breast cancer risk were most notable for postmenopausal women. These data support the plausibility of a role for sex steroid hormones in mediating the causal relationship between physical activity and the risk of breast cancer. See related reviews by Lynch et al., p. 11 and Swain et al., p. 16
Publisher: American Association for Cancer Research (AACR)
Date: 20-10-2021
DOI: 10.1158/1055-9965.EPI-21-0437
Abstract: The effect of physical activity on breast cancer risk may be partly mediated by sex steroid hormones. This review synthesized and appraised the evidence for an effect of physical activity on sex steroid hormones. Systematic searches were performed using MEDLINE (Ovid), EMBASE (Ovid), and SPORTDiscus to identify experimental studies and prospective cohort studies that examined physical activity and estrogens, progestins, and/or androgens, as well as sex hormone binding globulin (SHBG) and glucocorticoids in pre- and postmenopausal women. Meta-analyses were performed to generate effect estimates. Risk of bias was assessed, and the GRADE system was used to appraise quality of the evidence. Twenty-eight randomized controlled trials (RCT), 81 nonrandomized interventions, and six observational studies were included. Estrogens, progesterone, and androgens mostly decreased, and SHBG increased, in response to physical activity. Effect sizes were small, and evidence quality was graded moderate or high for each outcome. Reductions in select sex steroid hormones following exercise supports the biological plausibility of the first part of the physical activity–sex hormone–breast cancer pathway. The confirmed effect of physical activity on decreasing circulating sex steroid hormones supports its causal role in preventing breast cancer. See related reviews by Lynch et al., p. 11 and Drummond et al., p. 28
Publisher: American Association for Cancer Research (AACR)
Date: 29-03-2023
DOI: 10.1158/1055-9965.22354270
Abstract: Supplementary Table 2B presents the study characteristics of randomised cross-over trials
Publisher: American Association for Cancer Research (AACR)
Date: 05-2023
DOI: 10.1158/1055-9965.22725230.V1
Abstract: Supplementary Table 2A presents the study characteristics for parallel group RCTs
Publisher: American Association for Cancer Research (AACR)
Date: 29-03-2023
DOI: 10.1158/1055-9965.22354249.V1
Abstract: Supplementary Table 5 presents the outcomes of the meta-regression analysis conducted for IL-6
Publisher: American Association for Cancer Research (AACR)
Date: 29-03-2023
DOI: 10.1158/1055-9965.22354276
Abstract: Supplementary Table 1 presents the search terminology used in the systematic review
Publisher: American Association for Cancer Research (AACR)
Date: 29-03-2023
DOI: 10.1158/1055-9965.22354273
Abstract: Supplementary Table 2A presents the study characteristics for parallel group RCTs
Publisher: American Association for Cancer Research (AACR)
Date: 05-2023
DOI: 10.1158/1055-9965.22725260
Abstract: Forest plots for effects of physical activity interventions compared with usual activity in RCTs. A forest plot for ( b A /b ) adiponection and ( b B /b ) leptin.
Publisher: American Association for Cancer Research (AACR)
Date: 29-03-2023
DOI: 10.1158/1055-9965.22354255.V1
Abstract: Supplementary Table 3C present the risk of bias for the prospective cohort study, using the ROBINS-E
Publisher: American Association for Cancer Research (AACR)
Date: 05-2023
DOI: 10.1158/1055-9965.22725263
Abstract: Forest plots for effects of physical activity compared with usual activity control in RCTs. A forest plot for ( b A /b ) TNFα, ( b B /b ) IL6, and ( b C /b ) CRP.
Publisher: American Association for Cancer Research (AACR)
Date: 04-04-2023
DOI: 10.1158/1055-9965.22552090.V1
Abstract: Supplementary Table 3B presents the risk of bias for non-randomised interventions, using the ROBINS-I
Publisher: American Association for Cancer Research (AACR)
Date: 05-2023
DOI: 10.1158/1055-9965.22725224.V1
Abstract: Supplementary Table 2C presents the study characteristics for non-randomised interventions
Publisher: American Association for Cancer Research (AACR)
Date: 04-04-2023
DOI: 10.1158/1055-9965.22552087.V1
Abstract: Supplementary Table 3C present the risk of bias for the prospective cohort study, using the ROBINS-E
Publisher: American Association for Cancer Research (AACR)
Date: 05-2023
DOI: 10.1158/1055-9965.22725266
Abstract: PRISMA flow diagram. This figure incorporates literature search, screening, and study selection. Reasons for full-text inclusion included duplicate study, publication type (e.g., review), study design (e.g., cross-sectional design), population (e.g., male only), intervention/exposure (e.g., physical activity and diet), comparator (e.g., diet or medication), and outcomes (e.g., no inflammation measures).
Publisher: American Association for Cancer Research (AACR)
Date: 29-03-2023
DOI: 10.1158/1055-9965.22354297.V1
Abstract: Supplementary Figure 1A presents forest plots for physical activity and CRP, by menopausal status
Publisher: American Association for Cancer Research (AACR)
Date: 29-03-2023
DOI: 10.1158/1055-9965.22354267.V1
Abstract: Supplementary Table 2C presents the study characteristics for non-randomised interventions
Publisher: American Association for Cancer Research (AACR)
Date: 04-04-2023
DOI: 10.1158/1055-9965.22552099.V1
Abstract: Supplementary Table 2C presents the study characteristics for non-randomised interventions
Publisher: American Association for Cancer Research (AACR)
Date: 05-2023
DOI: 10.1158/1055-9965.22725266.V1
Abstract: PRISMA flow diagram. This figure incorporates literature search, screening, and study selection. Reasons for full-text inclusion included duplicate study, publication type (e.g., review), study design (e.g., cross-sectional design), population (e.g., male only), intervention/exposure (e.g., physical activity and diet), comparator (e.g., diet or medication), and outcomes (e.g., no inflammation measures).
Publisher: Springer Science and Business Media LLC
Date: 30-01-2023
Publisher: American Association for Cancer Research (AACR)
Date: 29-03-2023
DOI: 10.1158/1055-9965.22354282.V1
Abstract: Supplementary Figure 3B presents forest plots for physical activity and IL-6, by exercise type
Publisher: American Association for Cancer Research (AACR)
Date: 05-2023
DOI: 10.1158/1055-9965.22725251
Abstract: Supplementary Figure 2A present forest plots for physical activity and TNF-alpha, by menopausal status
Publisher: American Association for Cancer Research (AACR)
Date: 29-03-2023
DOI: 10.1158/1055-9965.22354258.V1
Abstract: Supplementary Table 3B presents the risk of bias for non-randomised interventions, using the ROBINS-I
Publisher: American Association for Cancer Research (AACR)
Date: 05-2023
DOI: 10.1158/1055-9965.22725200.V1
Abstract: Supplementary Table 6B presents findings of in idual randomised cross-over studies
Publisher: American Association for Cancer Research (AACR)
Date: 05-2023
DOI: 10.1158/1055-9965.22725254
Abstract: Supplementary Figure 1B presents forest plots for physical activity and CRP, by exercise type
Publisher: American Association for Cancer Research (AACR)
Date: 05-2023
DOI: 10.1158/1055-9965.22725257
Abstract: Supplementary Figure 1A presents forest plots for physical activity and CRP, by menopausal status
Publisher: American Association for Cancer Research (AACR)
Date: 29-03-2023
DOI: 10.1158/1055-9965.22354273.V1
Abstract: Supplementary Table 2A presents the study characteristics for parallel group RCTs
Publisher: American Association for Cancer Research (AACR)
Date: 04-04-2023
DOI: 10.1158/1055-9965.22552069
Abstract: Supplementary Table 6D presents findings of the prospective cohort study
Publisher: American Association for Cancer Research (AACR)
Date: 29-03-2023
DOI: 10.1158/1055-9965.22354291
Abstract: Supplementary Figure 2A present forest plots for physical activity and TNF-alpha, by menopausal status
Publisher: Revista Brasileira De Cancerologia (RBC)
Date: 10-02-2023
DOI: 10.32635/2176-9745.RBC.2023V69N1.3239
Abstract: Introduction: Oxygen consumption (VO2) is indicative of cardiorespiratory fitness (CRF) and lower levels are related to a higher risk of total mortality among in iduals with cancer whose therapy can have adverse consequences on the cardiovascular system. Objective: To examine the associations of patient-reported sociodemographic, clinical, anthropometric outcomes and functional variables with CRF in 69 women (55±10 years) and to identify whether walking is a predictor of peak VO2 variation in this population with breast cancer (BC). Method: Female BC survivors receiving hormone therapy after two types of surgery (breast-conserving and mastectomy) underwent a CRF test on a cycle ergometer to measure peak VO2. A questionnaire containing sociodemographic, clinical data, patient reported outcomes (PROs) (depressive symptoms, sleep quality, fatigue, body image) and self-reported walking and tests to measure body fat percentage, waist circumference, flexibility and shoulder range of motion (RoM) were performed. Results: Unemployment and retirement were associated with low CRF, as was the use of aromatase inhibitors instead of tamoxifen. Depressive symptoms, worse body image, greater waist circumference, less flexibility and shoulder RoM were also associated with low CRF. Walking duration, controlled for age and body mass index (BMI), is a 13% predictor of peak VO2 variance in this s le. Conclusion: These factors must be considered in understanding the CRF profile of BC survivors. As walking was a predictor of peak VO2 variance, it should be recommended as a type of physical activity for patients with BC using hormone therapy.
Publisher: American Association for Cancer Research (AACR)
Date: 29-03-2023
DOI: 10.1158/1055-9965.22354291.V1
Abstract: Supplementary Figure 2A present forest plots for physical activity and TNF-alpha, by menopausal status
Publisher: American Association for Cancer Research (AACR)
Date: 29-03-2023
DOI: 10.1158/1055-9965.22354264.V1
Abstract: Supplementary Table 2D presents the study characteristics of the prospective cohort study
Publisher: American Association for Cancer Research (AACR)
Date: 29-03-2023
DOI: 10.1158/1055-9965.22354270.V1
Abstract: Supplementary Table 2B presents the study characteristics of randomised cross-over trials
Publisher: American Association for Cancer Research (AACR)
Date: 29-03-2023
DOI: 10.1158/1055-9965.22354285.V1
Abstract: Supplementary Figure 3A presents forest plots for physical activity and IL-6, by menopausal status
Publisher: American Association for Cancer Research (AACR)
Date: 05-2023
DOI: 10.1158/1055-9965.22725263.V1
Abstract: Forest plots for effects of physical activity compared with usual activity control in RCTs. A forest plot for ( b A /b ) TNFα, ( b B /b ) IL6, and ( b C /b ) CRP.
Publisher: American Association for Cancer Research (AACR)
Date: 29-03-2023
DOI: 10.1158/1055-9965.22354297
Abstract: Supplementary Figure 1A presents forest plots for physical activity and CRP, by menopausal status
Publisher: American Association for Cancer Research (AACR)
Date: 29-03-2023
DOI: 10.1158/1055-9965.22354294
Abstract: Supplementary Figure 1B presents forest plots for physical activity and CRP, by exercise type
Publisher: Elsevier BV
Date: 12-1995
Publisher: Elsevier BV
Date: 1980
Publisher: American Association for Cancer Research (AACR)
Date: 05-2023
DOI: 10.1158/1055-9965.22725242
Abstract: Supplementary Figure 3B presents forest plots for physical activity and IL-6, by exercise type
Publisher: American Association for Cancer Research (AACR)
Date: 04-04-2023
DOI: 10.1158/1055-9965.22552096.V1
Abstract: Supplementary Table 2D presents the study characteristics of the prospective cohort study
Publisher: American Association for Cancer Research (AACR)
Date: 05-2023
DOI: 10.1158/1055-9965.22725245
Abstract: Supplementary Figure 3A presents forest plots for physical activity and IL-6, by menopausal status
Publisher: American Association for Cancer Research (AACR)
Date: 05-2023
DOI: 10.1158/1055-9965.22725248
Abstract: Supplementary Figure 2B presents forest plots for physical activity and TNF-alpha, by exercise type
Publisher: American Association for Cancer Research (AACR)
Date: 04-04-2023
DOI: 10.1158/1055-9965.22552129.V1
Abstract: Supplementary Figure 2A present forest plots for physical activity and TNF-alpha, by menopausal status
Publisher: American Association for Cancer Research (AACR)
Date: 05-2023
DOI: 10.1158/1055-9965.22725257.V1
Abstract: Supplementary Figure 1A presents forest plots for physical activity and CRP, by menopausal status
Publisher: American Association for Cancer Research (AACR)
Date: 04-04-2023
DOI: 10.1158/1055-9965.22552078
Abstract: Supplementary Table 6A presents findings of in idual parallel group RCTs
Publisher: American Association for Cancer Research (AACR)
Date: 04-04-2023
DOI: 10.1158/1055-9965.22552111
Abstract: Supplementary Table 2A presents the study characteristics for parallel group RCTs
Publisher: American Association for Cancer Research (AACR)
Date: 05-2023
DOI: 10.1158/1055-9965.22725260.V1
Abstract: Forest plots for effects of physical activity interventions compared with usual activity in RCTs. A forest plot for ( b A /b ) adiponection and ( b B /b ) leptin.
Publisher: American Association for Cancer Research (AACR)
Date: 04-04-2023
DOI: 10.1158/1055-9965.22552075
Abstract: Supplementary Table 6B presents findings of in idual randomised cross-over studies
Publisher: American Association for Cancer Research (AACR)
Date: 05-2023
DOI: 10.1158/1055-9965.22725197.V1
Abstract: Supplementary Table 6C presents findings of in idual non-randomised interventions
Publisher: American Association for Cancer Research (AACR)
Date: 05-2023
DOI: 10.1158/1055-9965.22725206.V1
Abstract: Supplementary Table 5 presents the outcomes of the meta-regression analysis conducted for IL-6
Publisher: American Association for Cancer Research (AACR)
Date: 05-2023
DOI: 10.1158/1055-9965.22725212.V1
Abstract: Supplementary Table 3C present the risk of bias for the prospective cohort study, using the ROBINS-E
Publisher: American Association for Cancer Research (AACR)
Date: 04-04-2023
DOI: 10.1158/1055-9965.22552072
Abstract: Supplementary Table 6C presents findings of in idual non-randomised interventions
Publisher: American Association for Cancer Research (AACR)
Date: 29-03-2023
DOI: 10.1158/1055-9965.22354243
Abstract: Supplementary Table 6B presents findings of in idual randomised cross-over studies
Publisher: American Association for Cancer Research (AACR)
Date: 29-03-2023
DOI: 10.1158/1055-9965.22354240
Abstract: Supplementary Table 6C presents findings of in idual non-randomised interventions
Publisher: American Association for Cancer Research (AACR)
Date: 05-2023
DOI: 10.1158/1055-9965.22725248.V1
Abstract: Supplementary Figure 2B presents forest plots for physical activity and TNF-alpha, by exercise type
Publisher: American Association for Cancer Research (AACR)
Date: 04-04-2023
DOI: 10.1158/1055-9965.22552126.V1
Abstract: Supplementary Figure 2B presents forest plots for physical activity and TNF-alpha, by exercise type
Publisher: American Association for Cancer Research (AACR)
Date: 05-2023
DOI: 10.1158/1055-9965.22725194
Abstract: Supplementary Table 6D presents findings of the prospective cohort study
Publisher: American Association for Cancer Research (AACR)
Date: 29-03-2023
DOI: 10.1158/1055-9965.22354279.V1
Abstract: Supplementary Figure 4 presents funnel plots for physical activity to inflammatory biomarkers meta-analyses
Publisher: American Association for Cancer Research (AACR)
Date: 05-2023
DOI: 10.1158/1055-9965.22725197
Abstract: Supplementary Table 6C presents findings of in idual non-randomised interventions
Publisher: American Association for Cancer Research (AACR)
Date: 05-2023
DOI: 10.1158/1055-9965.22725230
Abstract: Supplementary Table 2A presents the study characteristics for parallel group RCTs
Publisher: American Association for Cancer Research (AACR)
Date: 29-03-2023
DOI: 10.1158/1055-9965.22354237
Abstract: Supplementary Table 6D presents findings of the prospective cohort study
Publisher: American Association for Cancer Research (AACR)
Date: 05-2023
DOI: 10.1158/1055-9965.22725233
Abstract: Supplementary Table 1 presents the search terminology used in the systematic review
Publisher: American Association for Cancer Research (AACR)
Date: 04-04-2023
DOI: 10.1158/1055-9965.22552069.V1
Abstract: Supplementary Table 6D presents findings of the prospective cohort study
Publisher: American Association for Cancer Research (AACR)
Date: 29-03-2023
DOI: 10.1158/1055-9965.22354237.V1
Abstract: Supplementary Table 6D presents findings of the prospective cohort study
Publisher: American Association for Cancer Research (AACR)
Date: 05-2023
DOI: 10.1158/1055-9965.22725236
Abstract: GRADE appraisal for physical activity–inflammatory biomarkers pathways.
Publisher: American Association for Cancer Research (AACR)
Date: 05-2023
DOI: 10.1158/1055-9965.22725239.V1
Abstract: Supplementary Figure 4 presents funnel plots for physical activity to inflammatory biomarkers meta-analyses
Publisher: American Association for Cancer Research (AACR)
Date: 04-04-2023
DOI: 10.1158/1055-9965.22552108
Abstract: Supplementary Table 2B presents the study characteristics of randomised cross-over trials
Publisher: American Association for Cancer Research (AACR)
Date: 05-2023
DOI: 10.1158/1055-9965.22725254.V1
Abstract: Supplementary Figure 1B presents forest plots for physical activity and CRP, by exercise type
Publisher: American Association for Cancer Research (AACR)
Date: 05-2023
DOI: 10.1158/1055-9965.22725239
Abstract: Supplementary Figure 4 presents funnel plots for physical activity to inflammatory biomarkers meta-analyses
Publisher: American Association for Cancer Research (AACR)
Date: 04-04-2023
DOI: 10.1158/1055-9965.22552123
Abstract: Supplementary Figure 3A presents forest plots for physical activity and IL-6, by menopausal status
Publisher: American Association for Cancer Research (AACR)
Date: 04-04-2023
DOI: 10.1158/1055-9965.22552087
Abstract: Supplementary Table 3C present the risk of bias for the prospective cohort study, using the ROBINS-E
Publisher: American Association for Cancer Research (AACR)
Date: 04-04-2023
DOI: 10.1158/1055-9965.22552120
Abstract: Supplementary Figure 3B presents forest plots for physical activity and IL-6, by exercise type
Publisher: American Association for Cancer Research (AACR)
Date: 04-04-2023
DOI: 10.1158/1055-9965.22552084
Abstract: Supplementary Table 4 presents the outcomes of the meta-regression analysis conducted for CRP
Publisher: American Association for Cancer Research (AACR)
Date: 05-2023
DOI: 10.1158/1055-9965.22725194.V1
Abstract: Supplementary Table 6D presents findings of the prospective cohort study
Publisher: American Association for Cancer Research (AACR)
Date: 04-04-2023
DOI: 10.1158/1055-9965.22552081
Abstract: Supplementary Table 5 presents the outcomes of the meta-regression analysis conducted for IL-6
Publisher: American Association for Cancer Research (AACR)
Date: 04-04-2023
DOI: 10.1158/1055-9965.22552117.V1
Abstract: Supplementary Figure 4 presents funnel plots for physical activity to inflammatory biomarkers meta-analyses
Publisher: American Association for Cancer Research (AACR)
Date: 05-2023
DOI: 10.1158/1055-9965.22725245.V1
Abstract: Supplementary Figure 3A presents forest plots for physical activity and IL-6, by menopausal status
Publisher: American Association for Cancer Research (AACR)
Date: 05-2023
DOI: 10.1158/1055-9965.22725221
Abstract: Supplementary Table 2D presents the study characteristics of the prospective cohort study
Publisher: American Association for Cancer Research (AACR)
Date: 05-2023
DOI: 10.1158/1055-9965.22725203.V1
Abstract: Supplementary Table 6A presents findings of in idual parallel group RCTs
Publisher: American Association for Cancer Research (AACR)
Date: 05-2023
DOI: 10.1158/1055-9965.22725224
Abstract: Supplementary Table 2C presents the study characteristics for non-randomised interventions
Publisher: American Association for Cancer Research (AACR)
Date: 05-2023
DOI: 10.1158/1055-9965.22725251.V1
Abstract: Supplementary Figure 2A present forest plots for physical activity and TNF-alpha, by menopausal status
Publisher: American Association for Cancer Research (AACR)
Date: 29-03-2023
DOI: 10.1158/1055-9965.22354276.V1
Abstract: Supplementary Table 1 presents the search terminology used in the systematic review
Publisher: American Association for Cancer Research (AACR)
Date: 05-2023
DOI: 10.1158/1055-9965.22725227
Abstract: Supplementary Table 2B presents the study characteristics of randomised cross-over trials
Publisher: American Association for Cancer Research (AACR)
Date: 04-04-2023
DOI: 10.1158/1055-9965.22552117
Abstract: Supplementary Figure 4 presents funnel plots for physical activity to inflammatory biomarkers meta-analyses
Publisher: American Association for Cancer Research (AACR)
Date: 04-04-2023
DOI: 10.1158/1055-9965.22552123.V1
Abstract: Supplementary Figure 3A presents forest plots for physical activity and IL-6, by menopausal status
Publisher: American Association for Cancer Research (AACR)
Date: 04-04-2023
DOI: 10.1158/1055-9965.22552114
Abstract: Supplementary Table 1 presents the search terminology used in the systematic review
No related grants have been discovered for Leonessa Boing.